Cord Blood Center

What Cord Blood Center does

Cord Blood Center AG is a Swiss private cord blood bank founded in 1997 and headquartered in Luzern, Switzerland. The company collects, processes, and cryopreserves umbilical cord blood, umbilical cord tissue, and placental tissue for expectant parents, storing the material in liquid nitrogen at temperatures below -150°C across licensed laboratories in Austria, Slovakia, Romania, and the Czech Republic, with active branches in seven European countries (Austria, Czech Republic, Hungary, Italy, Slovakia, Switzerland, Romania) and a growing presence in Germany. The firm differentiates through a full-volume processing method that retains the entire cell content of cord blood rather than reducing volume, and through a Premium combined collection technique that draws from both umbilical cord vessels and superficial placental veins, reportedly yielding up to 40% more stem cells than standard collection. The company also operates the Slovak Placental Stem Cell Registry, a public cord blood registry integrated with WMDA and EMDIS — the only family bank in Europe to do so — and runs clinical studies in Slovakia and Romania on autologous cord blood treatment for cerebral palsy.

The company generates revenue through a combination of one-time collection and processing fees for each of its four core service lines (standard cord blood, premium cord blood plus placental blood, cord tissue, and placenta tissue), plus recurring annual storage fees that compound across a 180,000+ client base. Customer support programmes — including the Support Programme (covering up to EUR 155,000 in transplant costs), the Helping Hand programme routing clients to international treatment centers such as Duke University Hospital, and a Free Indicated Collection programme for families with affected children — deepen the customer relationship and reinforce retention over multi-decade storage horizons. Go-to-market relies on direct sales through local branch offices, country-specific websites, content marketing featuring patient success stories and physician endorsements, and B2B referral partnerships with obstetricians, maternity wards, and transplant centers. With more than 20 years of operational history, 400+ cord blood units released for treatment (the highest among European private cord blood banks), Cord Blood Center positions itself as the second-largest private cord blood bank in Europe by client volume.

Name

Cord Blood Center

Legal name

Cord Blood Center AG

Website

https://cordbloodcenter.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Short description

Cord Blood Center AG is a Swiss private cord blood bank founded in 1997 that collects, processes, and cryopreserves umbilical cord blood, cord tissue, and placental tissue for expectant parents across 7-8 European countries, serving more than 180,000 clients with one-time processing fees and recurring annual storage.

Ownership category

akta.pro rank

Product category

Cord Blood Banking / Stem Cell Storage Services

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industry

Blood, Organ & Tissue Donation Organizations (BPAGACAJ)

Keywords

• Cord blood banking
• Stem cell storage
• Cryopreservation services
• Perinatal tissue preservation
• Umbilical cord blood

Headquarters

HQ city

Luzern

HQ country

Switzerland

HQ region

Europe

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Cord Blood Collection and Processing: One-time payment for the collection and processing of umbilical cord blood, cord tissue, and/or placental tissue at birth.
2. Annual Storage Fees: Yearly recurring payment for long-term cryopreservation and storage of cord blood and tissues in liquid nitrogen containers.
3. Support Programme Coverage: Coverage of transplantation costs up to EUR 155,000 for diagnoses traditionally curable with own cord blood, plus personal expense coverage up to EUR 30,000.
4. Helping Hand Programme: Assistance programme helping families find suitable medical institutions for experimental treatment, organizing access to treatment at transplant centres in Europe and USA.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Cord Blood Center collects, processes, and cryopreserves umbilical cord blood, umbilical cord tissue, and placental tissue immediately after childbirth for expectant parents. The company offers four distinct collection types (standard cord blood, premium combined cord blood + placenta blood, cord tissue, and placenta tissue) and stores the samples in liquid nitrogen at temperatures below -150°C for decades. Customers pay a one-time fee for collection/processing plus an annual fee for long-term storage, with optional support programmes covering transplantation costs up to EUR 155,000.

Product overview

Cord Blood Center is a private cord blood bank offering preservation services for perinatal tissues including umbilical cord blood, cord tissue, and placenta tissue. The core service portfolio consists of four collection types: Standard Umbilical Cord Blood Collection (basic offering), Premium Umbilical Cord Blood + Placenta Blood Collection (combined collection yielding 40% more stem cells), Umbilical Cord Tissue Collection, and Placenta Tissue Collection. The company differentiates through its processing method that preserves the entire cell content without volume reduction. Beyond core storage, the company provides client support programmes including a Support Programme (covering transplantation costs up to EUR 155,000), the Helping Hand Programme (connecting families to experimental treatment centers including Duke University Hospital), and a Free Indicated Collection Programme for families with affected children. The company also operates the Slovak Placental Stem Cell Registry as a public cord blood registry, connected to international databases including WMDA and EMDIS.

Differentiator

Problem solved

Functional benefit

Products and services

• Umbilical Cord Blood Collection (Standard) Basic collection of umbilical cord blood from the umbilical cord vessels immediately after childbirth and before delivery of the placenta. The cord blood is frozen and stored in one bag for potential future medical use.
• Umbilical Cord Blood + Placenta Blood Collection (Premium) Innovative combined collection method that harvests cord blood from both umbilical cord vessels and surface veins of the placenta. Yields up to 40% more stem cells compared to standard collection. Blood from umbilical cord and placenta are processed and stored separately in two bags.
• Umbilical Cord Tissue Collection Collection of approximately 10-15cm of umbilical cord tissue for its mesenchymal stem cells. After processing, the tissue is divided into multiple cryotubes enabling multiple therapeutic uses. Complementary to cord blood collection.
• Placenta Tissue Collection Collection and storage of the entire placental tissue containing mesenchymal stem cells, blood-forming stem cells, and endothelial progenitors. Stored in multiple bags and cryotubes enabling multiple use. Available in Slovakia and Romania.
• Support Programme Client support programme offering professional consultations and coverage of transplantation costs up to EUR 155,000 for diagnoses traditionally curable with own cord blood, plus coverage of personal expenses up to EUR 30,000.
• Helping Hand Programme Programme offering assistance to families with stored cord blood in finding suitable medical institutions for experimental treatment, organizing access to treatment at transplant centres in Europe and the USA, including Duke University Hospital for cerebral palsy treatment.
• Programme of Free Indicated Collection Free collection, processing and storage of cord blood, cord tissue, and placenta for families where one child has a disease treatable with cord blood and the mother is expecting another child.
• Clinical Studies Programme Company-invested clinical trials in Slovakia and Romania focused on treatment of children with cerebral palsy using their own umbilical cord blood.

Quantifiable outcome

• Over 400 cord blood units released for treatment - highest number among European private cord blood banks
• +3 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• Duke University HospitalcoreStrategic or Co-development Partner · 1 January 2012Since 2012, Cord Blood Center has organized treatment of cerebral palsy at Duke University Hospital in the USA under the Helping Hand programme. The company covers travel and stay costs for clients receiving cord blood infusion therapy.
• Slovak Placental Stem Cell RegistrycoreStrategic or Co-development PartnerThe company operates and finances this public cord blood registry, the only family bank in Europe to do so. It is a member of WMDA and connected to EMDIS European Marrow Donor Information System.
• World Marrow Donor Association (WMDA)coreStrategic or Co-development PartnerInternational bone marrow and cord blood donors database. Slovak Placental Stem Cell Registry is a full member, allowing coordination of transplant searches globally.
• National Marrow Donor Program (NMDP)coreStrategic or Co-development PartnerUS National Hematopoietic Cell Donor Program / Global Transplant Network. Slovak Placental Stem Cell Registry is a member following NetCord FACT standards.
• NetCord FoundationcoreStrategic or Co-development PartnerInternational organization that sets quality standards for cord blood products. Slovak Placental Stem Cell Registry is an associate member.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ViaCord (Revvity): US-based private cord blood and cord tissue bank, now part of Revvity. Comparable product offering targeting expectant parents with similar one-time-plus-recurring revenue model; broader corporate parent and resources.
• CBR (Cord Blood Registry): One of the largest US private cord blood banks, now part of CooperCompanies. Directly comparable product offering and customer segment; broader scale and US market focus.
• Cryo-Cell International: US-listed pioneer and one of the largest private cord blood banks globally. Comparable in core service (umbilical cord blood banking) and recurring storage model; broader in geographic reach and public-market scale.

Direct peers

• FamiCord: Largest private cord blood bank group in Europe, operating multiple national brands across Poland, Germany, Spain, and other EU markets. Directly comparable as a multi-country private cord blood bank with similar collection, processing, and storage services.
• Biovault Family: UK-based private cord blood and tissue bank offering collection, processing, and long-term cryogenic storage. Comparable in product mix (cord blood, cord tissue, and placental tissue) and B2C expectant-parent GTM.
• Vita 34: Germany-headquartered private cord blood bank offering collection and cryogenic storage of cord blood and tissue. Directly comparable in product offering, customer segment (expectant parents), and European footprint.
• Cryo-Save (now Cellaviva): European private cord blood and tissue bank with operations across multiple EU countries. Closely comparable in service portfolio (umbilical cord blood and tissue storage) and target customer (expectant parents).
• Smart Cells: UK-headquartered private cord blood bank with international operations. Directly comparable as a private cord blood storage provider targeting expectant parents with similar subscription/recurring storage economics.
• Cells4Life: UK-based private cord blood and tissue bank offering multiple collection and storage tiers including whole-blood processing. Comparable in product structure, processing technology emphasis, and European market orientation.

Emerging players

• StemCyte: Hybrid public/private cord blood bank with operations in the US, India, and Taiwan. Comparable in dual public-private registry positioning — overlapping with Cord Blood Center's Slovak Placental Stem Cell Registry model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cord-blood-center-group-cbc

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cord Blood Center